TOLMAR
TOLMAR is a fully integrated pharmaceutical company focused on the development, approval, and commercialization of specialty pharmaceutical products, including a line of generic dermatology products, where TOLMAR is an established leader, and specialty injectable oncology products. Invention, development, and world-wide approval of ELIGARD for the palliative treatment of advanced prostate cancer has established TOLMAR as a leader dedicated to the urology community, providers, and patients. TOLMAR Pharmaceuticals is based in Lincolnshire, Illinois with TOLMAR headquarters, product development and manufacturing facilities based in Fort Collins, Colorado.
